Login to Your Account

European biotech investment surged 81% to $6.8B in 2017

By Cormac Sheridan
Staff Writer

Friday, January 5, 2018

DUBLIN – The European biotechnology sector enjoyed a period of sustained investor appetite in 2017, reflecting its ongoing ability to tap into global equity markets in order to fund development of its pipeline. Total investment reached $6.85 billion in disclosed transactions involving drug development firms.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription